dia 2022

Greenphire talks clinical trial challenges at DIA Global Annual Meeting

By Jenni Spinner contact

- Last updated on GMT

(sesame/iStock via Getty Images Plus)
(sesame/iStock via Getty Images Plus)

Related tags: DIA, Greenphire, Clinical trials, Patient recruitment, Patient centricity, Clinical research

The trial financial management company outlined a range of solutions designed to help trial teams get a handle on budgeting, patient reimbursement, and more.

Greenphire, a company centered on financial lifecycle management technology for clinical studies, discussed its range of offerings aimed at helping clinical research operations better streamline their studies. For example, its EnvisiX technology, first launched two years ago, is intended to streamline the budgeting process via access to up-to-date, fair-market-value data for clinical trials around the globe; according to the company, contract research organizations (CROs) in North America, Europe, Latin America, and Asia, have seen improvements in workflow, collaboration, and transparency.

OSP_GreenphireDIA_CW
Clareece West, executive vice president for commercial operations, Linical

Linical (a full-spectrum, multinational CRO) was among EnvisiX’s early adopters. Clareece West, executive vice president for commercial operations at Linical, said, “We are excited to partner with Greenphire, enabling access to the most robust and contemporary investigator grant negotiated actuals data in the industry. This data, along with the ease of building a budget through a simple and flexible tool, brings considerable value to our clients’ clinical development programs​."

Ashley Baxter, Greenphire’s clinical pricing analyst, presented a session at DIA, “Optimizing Study Budgeting and Access to Industry Indicative FMV Data to Accelerate Trial Timelines​” on June 22.

OSP_GreenphireDIA_AB
Ashley Baxter, clinical pricing analyst, Greenphire

Regardless of study size or resources of the sponsor initiating a study, building and negotiating an appropriate budget continues to be one of the most complex, time-consuming, and costly aspects of a clinical trial​,” Baxter said. “I am honored to share how tools like Greenphire’s EnvisiX, are able to optimize and simplify the process through an intuitive workflow and access to real-time FMV data.​”

 

Related news

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

Related suppliers

Follow us

Products

View more

Webinars